Submit Deal

STRAND THERAPEUTICS

HQ - Cambridge, MA

Summary

Strand Therapeutics Inc. is a biotechnology company that specializes in creating programmable mRNA therapeutics for the treatment of various diseases, with a focus on cancer and other life-threatening conditions.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 115 M

Avg. Deal Size£ 115 M

Market Context

Senior Management

Jake Becraft
CEO and Co-founder

Sort

07 Aug 2025|United States|Biotechnology

Target: STRAND THERAPEUTICS

Bidder: AMGEN VENTURES

3 Service Providers

2 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 114 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy